Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar version of the blockbuster cancer infection biologic. Neulasta brought in $4.5 billion for ...

Armlupeg, a biosimilar to Neulasta, is approved for reducing febrile neutropenia in non-myeloid malignancy patients undergoing myelosuppressive chemotherapy. Lupin's FDA-approved facility in India ...

As medications advance, so do devices used for drug delivery. Pharmaceutical engineers and designers are focused on how to make drug delivery systems easier, less painful, more sustainable, and better ...

YouTube, long renowned for its vast video library, has quietly established itself as a formidable music streaming service. Its dedicated app, YouTube Music, offers a curated collection of songs, ...

Neulasta (pegfilgrastim) is a prescription drug used to help prevent infection from certain types of chemotherapy and to treat radiation sickness. Neulasta can interact with certain other medications, ...

Neulasta (pegfilgrastim) is a brand-name injectable solution prescribed to treat radiation sickness and to help prevent infection due to chemotherapy. The cost of Neulasta with and without insurance ...

Lupin has received approval from Health Canada for pegfilgrastim, a biosimilar to Amgen's Neulasta. This product will be marketed under the brand name Armlupeg and manufactured at Lupin’s Biotech ...

Neulasta (pegfilgrastim) is a prescription drug that’s used to prevent serious infection from chemotherapy for certain cancers and treat radiation sickness. The drug comes as a liquid solution for ...

Neulasta (pegfilgrastim) is a brand-name drug that’s prescribed to treat radiation sickness and prevent certain complications of chemotherapy. Neulasta comes as an injectable solution. The dosage can ...

Coherus Biosciences has announced that the FDA has approved its on-body injector version of Udenyca (pegfilgrastim-cbqv) as biosimilar to Neulasta Onpro (pegfilgrastim with on-body injector). “Our ...